BioAtla Inc. (BCAB)
0.28
-0.02 (-8.17%)
At close: Mar 04, 2025, 11:27 AM
BioAtla Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 111.47M | 215.51M | 244.98M | 238.6M | 3.7M | 10.86M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 154K | 154K | 154K | 154K | 154K | 97K |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 4.93M | 4.92M | 2.31M | 2.08M | 803K | 1.8M |
| Total Current Assets | 116.41M | 220.43M | 247.29M | 240.68M | 4.51M | 12.66M |
| Property-Plant & Equipment | 3.1M | 5.15M | 6.98M | 4.1M | 4.67M | 3.88M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 3.25M | 5.3M | 7.13M | 4.26M | 4.83M | 3.98M |
| Total Assets | 119.66M | 225.74M | 254.42M | 244.94M | 9.34M | 16.64M |
| Account Payables | 3.82M | 4.23M | 1.18M | 2.46M | 5.14M | 1.96M |
| Deferred Revenue | n/a | n/a | n/a | 19.81M | 1.42M | 169K |
| Short-Term Debt | 1.62M | 3.04M | 2.78M | n/a | 9.71M | n/a |
| Other Current Liabilities | 22.9M | 15.86M | 15.86M | 10M | 10.45M | 7.07M |
| Total Current Liabilities | 28.34M | 23.13M | 19.81M | 32.26M | 26.72M | 9.2M |
| Long-Term Debt | 836K | 4.92M | 7.96M | 682K | 8.41M | 10.41M |
| Other Long-Term Liabilities | 19.81M | 17.35M | 15.82M | 2.02M | 8.59M | 15.99M |
| Total Long-Term Liabilities | 20.64M | 22.27M | 23.79M | 2.7M | 38.63M | 35.89M |
| Total Liabilities | 48.99M | 45.4M | 43.6M | 34.96M | 65.35M | 45.08M |
| Total Debt | 2.46M | 3.98M | 5.37M | 682K | 18.12M | 15M |
| Common Stock | 5K | 5K | 4K | 3K | 750K | 750K |
| Retained Earnings | -416.26M | -292.8M | -186.32M | -90.92M | -148.35M | -118.56M |
| Comprehensive Income | -0.00 | n/a | -0.00 | 0.00 | 0.00 | -1.38M |
| Shareholders Equity | 70.67M | 180.34M | 210.82M | 209.97M | -55.96M | -28.46M |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a |